SCHEMBL7970503

SCHEMBL7970503

CN1CCCC1CCNc1ccc2nc(N)c3cnc(-c4c(F)cccc4Cl)n3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 1/20 0.43
RAD52 P43351 2/20 0.42
ACP1 P24666 1/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ERAP1 Q9NZ08 1/20 0.38
GFER P55789 1/20 0.38
MITF O75030 1/20 0.38
PDE2A O00408 4/20 0.37
LCK P06239 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SLC2A1 P11166 1/20 0.36
TERT O14746 1/20 0.35
HRH2 P25021 1/20 0.35
HRH1 P35367 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
UHRF1 Q96T88 1/20 0.35
NMT1 P30419 1/20 0.35
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7980189 0.94 CAMK2D (0.44) CAMK2DRAD52ACP1NPC1RAB9A
SCHEMBL7969613 0.83 PDE2A (0.38) PDE2ALCK
SCHEMBL7983672 0.83 FGFR1 (0.53) LCK
SCHEMBL7979828 0.82 LCK (0.48) PDE2ALCK
SCHEMBL7983613 0.82 LCK (0.51) PDE2ALCK
SCHEMBL7987029 0.80 LCK (0.45) PDE2ALCK
SCHEMBL7983671 0.80 MAP3K8 (0.46) PDE2AMEN1KMT2A
SCHEMBL7980015 0.80 LCK (0.52) PDE2ALCK
SCHEMBL7982991 0.80 LCK (0.43) PDE2ALCK
SCHEMBL7987537 0.79 LCK (0.42) PDE2ALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed